Vasorum USA, Inc. announced FDA approval of the Celt ACD Plus system, which is designed for rapid arterial puncture closure ...

Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug Administration (FDA) approval of the Celt ACD® ...

This next-generation device enhances the proven Celt ACD® platform by providing physicians with a visual indicator for precise placement and closure, particularly beneficial in cases where ...

(MENAFN- PR Newswire) The Celt ACD ® PLUS is an innovative small-bore closure device available in 5F, 6F, and 7F sizes, designed for rapid arterial puncture closure following percutaneous ...